Biological Agents for Controlling Excessive Scarring
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference29 articles.
1. Novel Opportunities in the Treatment and Prevention of Scarring
2. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
3. Analysis of p53 Gene Mutations in Keloids Using Polymerase Chain Reaction–Based Single-Strand Conformational Polymorphism and DNA Sequencing
4. p53 and apoptosis alterations in keloids and keloid fibroblasts
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies;Heliyon;2024-09
2. Interferon Therapy for Hypertrophic Scars and Keloids;Wound Healing [Working Title];2021-03-23
3. Normal and keloid fibroblasts are differentially influenced by IFN‐γ and triamcinolone as well as by their combination;Wound Repair and Regeneration;2019-04-29
4. Update on Keloid Management: Clinical and Basic Science Advances;Advances in Wound Care;2012-10
5. Mast Cells in Tissue Healing: From Skin to the Gastrointestinal Tract;Current Pharmaceutical Design;2011-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3